Cemtrex Cash and Cash Equivalents Up 312% to $20.5M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy CETX?
Cash and cash equivalents increased 312% to $20.5M, compared to the prior year of $5M. Cemtrex chairman and CEO, Saagar Govil, commented on the results: "Fiscal Q1 2026 was a quarter of decisive action. We strengthened our balance sheet, delivered continued revenue growth driven by our Industrial segment. Operating loss for the quarter was $2.8 million, compared to $2.3 million in the prior year period, primarily reflecting lower gross margin in Security and certain one-time expenses, including a write-off of obsolete demo equipment and elevated legal and transaction costs related to acquisition activity and other matters. Excluding these non-recurring items, our focus remains on improving segment contribution and lowering the run-rate cost structure."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CETX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CETX
About CETX
Cemtrex, Inc. is a diversified industrial and technology company. The Company is operating across the Security, Industrial, and Aerospace & Defense sectors. Its Security segment operates through Vicon Industries, which provides advanced video management software, high-performance security cameras, and integrated surveillance solutions for enterprise, government, and critical infrastructure customers. Its Industrial segment, operates through Advanced Industrial Services (AIS), delivers specialized rigging, millwrighting, process piping, and equipment installation services to manufacturers nationwide. AIS installs high precision equipment in a wide variety of industrial markets like automotive, printing and graphics, industrial automation, packaging, and chemicals, among others. Its Aerospace & Defense segment provides mission-critical engineering, instrumentation, and sensing solutions supporting aerospace, defense, and space-based programs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cemtrex Reports Q1 2023 Financial Results with Significant Losses
- Net Loss Overview: Cemtrex reported a net loss of $20.6 million for Q1 2023, primarily driven by non-cash items related to debt settlement, indicating significant financial management pressures that could impact future financing capabilities.
- Revenue Growth: Despite the losses, Cemtrex's revenue increased by 17.5% year-over-year to $16.1 million, demonstrating resilience in market demand that may support future business expansion efforts.
- Gross Profit and Margin: The company reported a gross profit of $5.6 million with a gross margin of 35%, reflecting efforts in cost control, although overall profitability still requires improvement for sustainable growth.
- Operating Loss: Cemtrex faced an operating loss of $2.8 million, highlighting challenges in operational efficiency and cost management that may affect investor confidence in the company's future performance.
See More
Cemtrex Secures $4 Million Share Purchase Agreement with Institutional Investor
- Share Purchase Agreement: Cemtrex has entered into a definitive agreement to purchase approximately 1,469,507 shares at $2.722 per share, expected to generate $4 million in gross proceeds, thereby strengthening its capital base for future growth.
- Planned Use of Funds: The net proceeds from this transaction will be allocated for general corporate purposes, including working capital and potential acquisitions, indicating the company's strategic intent to expand its operations and enhance market competitiveness.
- Compliance and Transparency: The offering is made under an effective S-3 registration statement, ensuring compliance with SEC regulations, which enhances investor confidence and improves the company's transparency.
- Market Positioning Enhancement: Cemtrex's diversified operations in security technology and industrial services, combined with this financing, aim to further solidify its competitive position in the aerospace, defense, and industrial markets.
See More
Tilray Brands Reports Q2 Earnings Beat, Shares Surge 7.3%
- Earnings Beat: Tilray Brands reported Q2 earnings of $0.01 per share, surpassing the market expectation of a $0.20 loss, indicating a significant improvement in profitability that boosts investor confidence.
- Revenue Growth: The company achieved quarterly revenue of $217.51 million, exceeding the consensus estimate of $210.95 million, demonstrating success in market demand and sales strategies, which further solidifies its market position.
- Stock Price Surge: Following the positive earnings report, Tilray Brands' shares rose 7.3% to $9.80 in pre-market trading, reflecting investor optimism about the company's future growth potential.
- Positive Market Reaction: The strong performance post-earnings release may attract more investor attention, enhancing the company's appeal in a competitive market landscape.
See More
Cemtrex Completes Acquisition of Invocon, Launching Aerospace & Defense Segment
- Acquisition Completed: Cemtrex has finalized its acquisition of Invocon, marking the official launch of its Aerospace & Defense segment, with Invocon boasting nearly 40 years of industry experience and generating average annual revenues of approximately $7.4 million and operating income of about $1.7 million, indicating strong profitability and market potential.
- Government Contract Advantage: Invocon has recently secured contracts under the Missile Defense Agency's SHIELD program, with a total ceiling of up to $151 billion, aimed at accelerating the development and deployment of innovative missile defense capabilities, reflecting the Department of Defense's emphasis on speed and adaptability, thereby enhancing Cemtrex's competitiveness in the defense sector.
- Growing Market Demand: As global conflicts escalate and commercial space investments expand, the demand for reliable engineering capabilities continues to rise, and through the acquisition of Invocon, Cemtrex is well-positioned to meet the needs of both defense and aerospace sectors, driving long-term growth for the company.
- Strategic Integration Plans: Following the acquisition, Cemtrex will focus on integrating Invocon's customer relationships and program execution while expanding participation in missile defense and aerospace projects, ensuring sustained earnings growth and an increase in market share.
See More
OceanFirst Financial Corp. Announces $579 Million All-Stock Acquisition of Flushing, Shares Drop 7.4%
- Acquisition Announcement: OceanFirst Financial Corp. has announced a $579 million all-stock acquisition of Flushing Financial, which aims to enhance market share, yet the stock price fell 7.4%, indicating a negative market reaction to the deal.
- Market Reaction: Following the acquisition news, OceanFirst's shares dropped to $18.15, reflecting investor uncertainty regarding integration risks and potential returns, which may impact the company's short-term capital flow.
- Strategic Implications: This acquisition represents OceanFirst's strategic move to expand its presence in the New Jersey market, potentially increasing its customer base and long-term profitability, although short-term stock volatility may undermine investor confidence.
- Investor Focus: As the acquisition progresses, the market will closely monitor how OceanFirst manages the integration process and its impact on financial performance, especially in the current economic climate where investors are cautious about the banking sector.
See More
FONAR Corporation Confirms Take-Private Deal, Shares Surge 28%
- Take-Private Confirmation: FONAR Corporation confirmed its take-private deal, leading to a 28% surge in shares to $18.82, reflecting strong market confidence that may provide the company with greater flexibility for future growth.
- Patent Approval Boost: Autonomix Medical, Inc. shares rose 30% to $0.6943 after the European Patent Office granted Patent No. EP4230133, indicating significant advancements in cardiac tissue treatment technology that could enhance its competitive position in the market.
- Return to Profitability: Cemtrex, Inc. saw a 40% increase in shares to $2.95 as the company announced a return to profitability despite ongoing going-concern warnings, showcasing investor optimism regarding its future prospects.
- Merger Agreement Impact: Flushing Financial Corporation shares fell 8% to $15.46 following the announcement of a merger agreement with OceanFirst Financial Corp. and a $225 million strategic investment, indicating mixed market reactions that could affect the future performance of both companies.
See More
Cemtrex Reports Q1 2023 Financial Results with Significant Losses
- Net Loss Overview: Cemtrex reported a net loss of $20.6 million for Q1 2023, primarily driven by non-cash items related to debt settlement, indicating significant financial management pressures that could impact future financing capabilities.
- Revenue Growth: Despite the losses, Cemtrex's revenue increased by 17.5% year-over-year to $16.1 million, demonstrating resilience in market demand that may support future business expansion efforts.
- Gross Profit and Margin: The company reported a gross profit of $5.6 million with a gross margin of 35%, reflecting efforts in cost control, although overall profitability still requires improvement for sustainable growth.
- Operating Loss: Cemtrex faced an operating loss of $2.8 million, highlighting challenges in operational efficiency and cost management that may affect investor confidence in the company's future performance.
See More
Cemtrex Secures $4 Million Share Purchase Agreement with Institutional Investor
- Share Purchase Agreement: Cemtrex has entered into a definitive agreement to purchase approximately 1,469,507 shares at $2.722 per share, expected to generate $4 million in gross proceeds, thereby strengthening its capital base for future growth.
- Planned Use of Funds: The net proceeds from this transaction will be allocated for general corporate purposes, including working capital and potential acquisitions, indicating the company's strategic intent to expand its operations and enhance market competitiveness.
- Compliance and Transparency: The offering is made under an effective S-3 registration statement, ensuring compliance with SEC regulations, which enhances investor confidence and improves the company's transparency.
- Market Positioning Enhancement: Cemtrex's diversified operations in security technology and industrial services, combined with this financing, aim to further solidify its competitive position in the aerospace, defense, and industrial markets.
See More
Tilray Brands Reports Q2 Earnings Beat, Shares Surge 7.3%
- Earnings Beat: Tilray Brands reported Q2 earnings of $0.01 per share, surpassing the market expectation of a $0.20 loss, indicating a significant improvement in profitability that boosts investor confidence.
- Revenue Growth: The company achieved quarterly revenue of $217.51 million, exceeding the consensus estimate of $210.95 million, demonstrating success in market demand and sales strategies, which further solidifies its market position.
- Stock Price Surge: Following the positive earnings report, Tilray Brands' shares rose 7.3% to $9.80 in pre-market trading, reflecting investor optimism about the company's future growth potential.
- Positive Market Reaction: The strong performance post-earnings release may attract more investor attention, enhancing the company's appeal in a competitive market landscape.
See More
Cemtrex Completes Acquisition of Invocon, Launching Aerospace & Defense Segment
- Acquisition Completed: Cemtrex has finalized its acquisition of Invocon, marking the official launch of its Aerospace & Defense segment, with Invocon boasting nearly 40 years of industry experience and generating average annual revenues of approximately $7.4 million and operating income of about $1.7 million, indicating strong profitability and market potential.
- Government Contract Advantage: Invocon has recently secured contracts under the Missile Defense Agency's SHIELD program, with a total ceiling of up to $151 billion, aimed at accelerating the development and deployment of innovative missile defense capabilities, reflecting the Department of Defense's emphasis on speed and adaptability, thereby enhancing Cemtrex's competitiveness in the defense sector.
- Growing Market Demand: As global conflicts escalate and commercial space investments expand, the demand for reliable engineering capabilities continues to rise, and through the acquisition of Invocon, Cemtrex is well-positioned to meet the needs of both defense and aerospace sectors, driving long-term growth for the company.
- Strategic Integration Plans: Following the acquisition, Cemtrex will focus on integrating Invocon's customer relationships and program execution while expanding participation in missile defense and aerospace projects, ensuring sustained earnings growth and an increase in market share.
See More
OceanFirst Financial Corp. Announces $579 Million All-Stock Acquisition of Flushing, Shares Drop 7.4%
- Acquisition Announcement: OceanFirst Financial Corp. has announced a $579 million all-stock acquisition of Flushing Financial, which aims to enhance market share, yet the stock price fell 7.4%, indicating a negative market reaction to the deal.
- Market Reaction: Following the acquisition news, OceanFirst's shares dropped to $18.15, reflecting investor uncertainty regarding integration risks and potential returns, which may impact the company's short-term capital flow.
- Strategic Implications: This acquisition represents OceanFirst's strategic move to expand its presence in the New Jersey market, potentially increasing its customer base and long-term profitability, although short-term stock volatility may undermine investor confidence.
- Investor Focus: As the acquisition progresses, the market will closely monitor how OceanFirst manages the integration process and its impact on financial performance, especially in the current economic climate where investors are cautious about the banking sector.
See More
FONAR Corporation Confirms Take-Private Deal, Shares Surge 28%
- Take-Private Confirmation: FONAR Corporation confirmed its take-private deal, leading to a 28% surge in shares to $18.82, reflecting strong market confidence that may provide the company with greater flexibility for future growth.
- Patent Approval Boost: Autonomix Medical, Inc. shares rose 30% to $0.6943 after the European Patent Office granted Patent No. EP4230133, indicating significant advancements in cardiac tissue treatment technology that could enhance its competitive position in the market.
- Return to Profitability: Cemtrex, Inc. saw a 40% increase in shares to $2.95 as the company announced a return to profitability despite ongoing going-concern warnings, showcasing investor optimism regarding its future prospects.
- Merger Agreement Impact: Flushing Financial Corporation shares fell 8% to $15.46 following the announcement of a merger agreement with OceanFirst Financial Corp. and a $225 million strategic investment, indicating mixed market reactions that could affect the future performance of both companies.
See More
